February 2001
Joe Weider's Muscle & Fitness;Feb2001, Vol. 62 Issue 2, p40
Reports the development of a vaccine that protects women against genital herpes.


Related Articles

  • Theracine vaccine lifts hopes as HSV2 treatment. Hilton, Lisette // Dermatology Times;Sep2000, Vol. 21 Issue 9, p18 

    Reports on the development of a vaccine at the University of Maryland which could allow the body's immune system to effectively suppress recurrent genital herpes so that sufferers will no longer deal with the symptoms of HS2V outbreaks. Positive results of the vaccine, called theracine, in...

  • Vaccines Against Genital Herpes: Progress and Limitations. Morrison, L.A. // Drugs;2002, Vol. 62 Issue 8, p1119 

    Herpes simplex viruses (HSV) cause lifelong persistent infections with numerous disease manifestations. Genital herpes infections are widespread in populations throughout the world and a vaccine to protect against or subdue established genital herpes infections has been under development for...

  • Antiviral vaccine may reduce genital herpes episodes, help prevent spread.  // Modern Medicine;Apr94, Vol. 62 Issue 4, p31 

    Reports on the results of a study assessing the effectiveness of a new vaccine in reducing the rate of genital herpes episodes. Study of 98 patients with recurring genital herpes; Recombinant HSV-2 glycoproteins contained in the vaccine.

  • Study shows ineffectiveness of herpes vaccine. Hilton, Lisette // Dermatology Times;Nov99, Vol. 20 Issue 11, p11 

    Focuses on a study of a potential candidate vaccine for genital herpes. Findings by doctor Stephen Straus and colleagues; Failure to stop people from acquiring the virus; Effectiveness in protecting several species of animals; Complex relationship between herpes simplex virus and humans.

  • Herpes vaccine works for women exclusively. Hannapel, Coriene E. // Dermatology Times;Oct2000, Vol. 21 Issue 10, p1 

    Reports on the effectiveness of a vaccine against genital herpes disease that works only for women who are seronegative for herpes simplex virus-1 and 2. Success of vaccine due to an adjuvant; Composition of the adjuvant; Results of experimental studies; Speculations on vaccine efficacy only in...

  • Antiviral vaccine rebounds versus herpes. Kuznar, Wayne // Dermatology Times;Jun2001, Vol. 22 Issue 6, p1 

    Discusses the results of a study on the ability of a glucoprotein vaccine to induce protection against genital herpes in women with no evidence of either herpes simplex virus or HSV 2 infection. Patient characteristics; Patient tolerance; Low-grade fever as main side effect; Hope for improving...

  • Genital herpes vaccine shows limited promise. Stephenson, Joan; Stephenson, J // JAMA: Journal of the American Medical Association;10/18/2000, Vol. 284 Issue 15, p1913 

    States that a vaccine against genital herpes infections appears to protect people against the disease, but has limitations that may have implications for vaccines against sexually transmitted diseases (STD). Report unveiled at the 40th Interscience Conference on Antimicrobial Agents and...

  • A vaccine strategy that protects against genital herpes by establishing local memory T cells. Shin, Haina; Iwasaki, Akiko // Nature;11/15/2012, Vol. 491 Issue 7424, p463 

    Most successful existing vaccines rely on neutralizing antibodies, which may not require specific anatomical localization of B cells. However, efficacious vaccines that rely on T cells for protection have been difficult to develop, as robust systemic memory T-cell responses do not necessarily...

  • BioVEX Reaches the Clinic with Genital Herpes Vaccine. Moran, Nuala // BioWorld International;8/27/2008, Vol. 13 Issue 35, p3 

    The article reports that BioVEX Inc. has won approval from British regulators for a Phase I study of its genital herpes vaccine that is based on the company's ImmunoVEX live-attenuated vaccine technology. The product has been genetically engineered to prevent it from replicating while having the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics